0.0 0.0 0 Underwriting Agreement and upon closing of the Unit Offering, we issued to the Underwriter warrants to purchase up to 2,173,913 shares of Common Stock (the “Underwriter Warrants” and, together with the Common Warrants and the Pre-Funded Warrants, the “Warrants”), which is 5.0% of the aggregate number of Shares and Shares issuable upon exercise of the Pre-Funded Warrants sold in the Unit Offering. The Underwriter Warrants are exercisable at any time and from time to time, in whole or in part, commencing from six months after June 29, 2022 (the "Effective Date") and ending five years from the Effective Date, at a price per share equal to $0.23, which is the public offering price per unit. 1 Non-accelerated Filer 1 1 Q2 false 0001755953 --12-31 2022 DE Akerna Corp. 0 1 0001755953 2022-06-02 2022-06-30 0001755953 kern:OtherRevenuesMember 2022-04-01 2022-06-30 0001755953 2020-06-01 2020-06-09 0001755953 kern:ConsultingRevenuesMember 2022-04-01 2022-06-30 0001755953 kern:SoftwareRevenuesMember 2022-04-01 2022-06-30 0001755953 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001755953 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001755953 kern:SpecialVotingPreferredStockMember 2022-01-01 2022-03-31 0001755953 us-gaap:RetainedEarningsMember 2022-03-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001755953 us-gaap:CommonStockMember 2022-03-31 0001755953 kern:SpecialVotingPreferredStockMember 2022-03-31 0001755953 kern:SpecialVotingPreferredStockMember 2021-06-30 0001755953 kern:SpecialVotingPreferredStockMember 2021-04-01 2021-06-30 0001755953 kern:MtechMember kern:PublicWarrantMember us-gaap:IPOMember 2018-02-08 0001755953 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001755953 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001755953 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001755953 kern:SpecialVotingPreferredStockMember 2022-04-01 2022-06-30 0001755953 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0001755953 2021-06-01 2021-06-30 0001755953 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001755953 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001755953 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-06-30 0001755953 us-gaap:ExchangeableDebtMember 2021-01-01 2021-06-30 0001755953 kern:PrivateWarrantMember 2022-04-01 2022-06-30 0001755953 kern:PrivateWarrantMember 2022-03-31 0001755953 kern:PrivateWarrantMember 2021-01-01 2021-06-30 0001755953 country:CA 2021-01-01 2021-06-30 0001755953 2021-10-05 0001755953 country:US 2021-01-01 2021-06-30 0001755953 kern:NonEnterpriseMember 2021-01-01 2021-06-30 0001755953 us-gaap:CorporationMember 2021-01-01 2021-06-30 0001755953 kern:OtherRevenuesMember 2021-01-01 2021-06-30 0001755953 kern:ConsultingRevenuesMember 2021-01-01 2021-06-30 0001755953 kern:SoftwareRevenuesMember 2021-01-01 2021-06-30 0001755953 kern:TreComSystemsGroupIncMember 2021-04-02 0001755953 kern:TechMagicUSALLCMember 2020-11-23 0001755953 kern:TechMagicUSALLCMember 2022-01-01 2022-06-30 0001755953 kern:ThreeSixtyFiveCannabisMember 2021-10-01 0001755953 kern:CannabisMember 2021-10-01 0001755953 kern:ThreeSixtyFiveCannabisMember 2022-01-01 2022-06-30 0001755953 country:CA 2021-12-31 0001755953 country:US 2021-12-31 0001755953 country:CA 2022-06-30 0001755953 country:US 2022-06-30 0001755953 kern:AmpleOrganicsMember 2022-06-30 0001755953 us-gaap:RetainedEarningsMember 2021-03-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001755953 us-gaap:CommonStockMember 2021-03-31 0001755953 us-gaap:RetainedEarningsMember 2021-12-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001755953 us-gaap:CommonStockMember 2021-12-31 0001755953 kern:SpecialVotingPreferredStockMember 2021-12-31 0001755953 kern:ExchangeableSharesMember 2021-12-31 0001755953 kern:ExchangeableSharesMember 2022-06-30 0001755953 kern:PrivateWarrantMember 2021-01-01 2021-12-31 0001755953 kern:PrivateWarrantMember 2021-12-31 0001755953 kern:PrivateWarrantMember 2022-06-30 0001755953 kern:PrivateWarrantMember 2022-06-30 0001755953 kern:PrivateWarrantMember 2021-03-31 0001755953 us-gaap:RetainedEarningsMember 2022-06-30 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001755953 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001755953 us-gaap:CommonStockMember 2022-06-30 0001755953 kern:SpecialVotingPreferredStockMember 2022-06-30 0001755953 kern:OtherRevenuesMember 2021-04-01 2021-06-30 0001755953 kern:ConsultingRevenuesMember 2021-04-01 2021-06-30 0001755953 kern:SoftwareRevenuesMember 2021-04-01 2021-06-30 0001755953 kern:PrivateWarrantMember 2021-12-31 0001755953 kern:PrivateWarrantMember 2021-04-01 2021-06-30 0001755953 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001755953 2021-06-30 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001755953 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001755953 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001755953 2021-04-01 2021-06-30 0001755953 2021-01-01 2021-03-31 0001755953 kern:ViridianSciencesMember 2022-01-01 2022-06-30 0001755953 2021-01-01 2021-06-30 0001755953 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001755953 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001755953 kern:OneOtherGovernmentCustomerMember kern:SalesRevenuesMember us-gaap:RevenueFromRightsConcentrationRiskMember 2022-01-01 2022-06-30 0001755953 kern:TwoGovernmentClientMember us-gaap:RevenueFromRightsConcentrationRiskMember kern:AccountReceivableMember 2021-01-01 2021-12-31 0001755953 kern:TwoGovernmentCustomersOneMember kern:AccountReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001755953 kern:PrivateWarrantMember 2022-01-01 2022-06-30 0001755953 kern:PrivateWarrantMember 2020-12-31 0001755953 2022-01-01 2022-06-30 0001755953 us-gaap:CommonStockMember 2018-02-08 0001755953 kern:PrivateWarrantMember 2022-01-01 2022-06-30 0001755953 us-gaap:ConvertibleDebtMember 2022-01-01 2022-06-30 0001755953 kern:OneGovernmentClientMember kern:SalesRevenuesMember 2022-01-01 2022-06-30 0001755953 kern:OtherRevenuesMember 2022-01-01 2022-06-30 0001755953 kern:SoftwareRevenuesMember 2022-01-01 2022-06-30 0001755953 kern:ConsultingRevenuesMember 2022-01-01 2022-06-30 0001755953 2020-12-31 0001755953 us-gaap:RetainedEarningsMember 2020-12-31 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001755953 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001755953 us-gaap:CommonStockMember 2020-12-31 0001755953 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001755953 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001755953 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001755953 kern:OneOtherGovernmentCustomerMember kern:SalesRevenuesMember us-gaap:RevenueFromRightsConcentrationRiskMember 2021-01-01 2021-06-30 0001755953 kern:OneOtherGovernmentCustomerMember kern:SalesRevenuesMember 2022-01-01 2022-06-30 0001755953 2020-06-09 0001755953 us-gaap:ExchangeableDebtMember 2022-01-01 2022-06-30 0001755953 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-06-30 0001755953 kern:MtechMember kern:PrivateWarrantMember us-gaap:PrivatePlacementMember us-gaap:WarrantMember 2018-02-08 0001755953 country:US 2022-01-01 2022-06-30 0001755953 country:CA 2022-01-01 2022-06-30 0001755953 kern:MtechMember kern:PrivateWarrantMember us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2018-02-08 0001755953 us-gaap:CommonStockMember 2021-06-30 0001755953 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001755953 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001755953 2021-12-31 0001755953 2021-03-31 0001755953 us-gaap:RetainedEarningsMember 2021-06-30 0001755953 2022-06-30 0001755953 kern:MtechMember kern:PublicWarrantMember us-gaap:IPOMember us-gaap:WarrantMember 2018-02-08 0001755953 kern:SalesRevenuesMember kern:OneOtherGovernmentCustomerMember 2021-01-01 2021-12-31 0001755953 kern:TwoGovernmentCustomersOneMember kern:AccountReceivableMember 2022-01-01 2022-06-30 0001755953 kern:MtechMember kern:PublicWarrantMember us-gaap:IPOMember us-gaap:CommonStockMember 2018-02-08 0001755953 kern:PrivateWarrantMember 2021-06-30 0001755953 kern:MtechMember kern:PublicWarrantMember us-gaap:OverAllotmentOptionMember 2018-02-08 0001755953 kern:MtechMember kern:PrivateWarrantMember us-gaap:PrivatePlacementMember 2018-02-08 0001755953 2022-04-01 2022-06-30 0001755953 2022-03-31 0001755953 kern:MtechMember 2018-02-08 0001755953 kern:AmpleReportingUnitMember 2022-06-30 0001755953 kern:ThreeSixtyFiveCannabisMember 2022-06-30 0001755953 kern:ThreeSixtyFiveCannabisMember 2021-01-01 2021-12-31 0001755953 kern:CannabisMember 2021-10-09 2021-10-10 0001755953 us-gaap:ConvertibleDebtSecuritiesMember 2022-06-30 0001755953 us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001755953 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-06-30 0001755953 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001755953 kern:SpecialVotingPreferredStockMember 2021-12-31 0001755953 kern:SpecialVotingPreferredStockMember 2022-06-30 0001755953 kern:SpecialVotingPreferredStockMember 2020-12-31 0001755953 kern:SpecialVotingPreferredStockMember 2021-01-01 2021-03-31 0001755953 kern:SpecialVotingPreferredStockMember 2021-03-31 0001755953 kern:TreComSystemsGroupIncMember 2021-01-01 2021-12-31 0001755953 kern:TechMagicUSALLCMember 2021-01-01 2021-12-31 0001755953 us-gaap:CorporationMember 2022-01-01 2022-06-30 0001755953 2022-01-01 2022-03-31 0001755953 kern:NonEnterpriseMember 2022-01-01 2022-06-30 0001755953 kern:PreFundedWarrantsMember 2022-06-30 0001755953 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-06-30 0001755953 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-06-30 0001755953 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001755953 2022-05-31 0001755953 2022-05-15 2022-05-23 0001755953 2022-07-01 2022-07-05 0001755953 srt:MinimumMember kern:UnderwriterWarrantsMember 2022-06-30 0001755953 2022-05-01 2022-05-31 0001755953 2022-08-11 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares kern:Customers
 


UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


 

 For the quarterly period ended June 30, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from / to

 

Commission file number 001-39096

 

AKERNA CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

 

83-2242651

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

   

 

 

1550 Larimer Street, #246 Denver, Colorado

 

80202

(Address of principal executive offices)

 

(Zip Code)

 

 Registrant’s telephone number, including area code: (888) 932-6537

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share 

 

KERN

 

Nasdaq Stock Market LLC (Nasdaq Capital Market)

Warrants to purchase one share of common stock

 

KERNW

 

Nasdaq Stock Market LLC (Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

☒ 

 

Smaller reporting company

 

 

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes  No 

 

As of August 11, 2022, there were 80,285,241 shares of the registrant’s common stock, par value $0.0001 per share, outstanding. 


 

 





INDEX

Page Number




PART I FINANCIAL INFORMATION
    Item 1. Condensed Consolidated Balance Sheets (unaudited) 1

Condensed Consolidated Statements of Operations (unaudited) 2

Condensed Consolidated Statements of Comprehensive Loss (unaudited) 3

Condensed Consolidated Statements of Changes in Equity (unaudited) 4

Condensed Consolidated Statements of Cash Flows (unaudited) 6

Notes to Condensed Consolidated Financial Statements (unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
Item 3. Quantitative and Qualitative Disclosures About Market Risk 37
Item 4. Controls and Procedures 38



PART II OTHER INFORMATION 



Item 1. Legal Proceedings 40
   Item 1A. Risk Factors 40
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42
Item 3. Defaults Upon Senior Securities 42
Item 4. Mine Safety Disclosures 42
Item 5. Other Information 42
Item 6. Exhibits 43

SIGNATURES 44


i


AKERNA CORP.
 Condensed Consolidated Balance Sheets
  (unaudited)


 

June 30,

 


December 31,

 

 

2022

 


2021

 

Assets


 


 

 

Current assets: 

 

 


 

 

Cash

$

5,124,553

 


$

13,934,265

 

Restricted cash

 

8,261

 


 

508,261

 

Accounts receivable, net

 

1,882,084

 


 

1,403,774

 

Prepaid expenses and other current assets

 

2,155,446

 


 

2,383,764

 

Total current assets

 

9,170,344

 


 

18,230,064

 

 

 

 

 


 

 

 

Fixed assets, net

 

143,026

 


 

153,151

 

Investment, net

 

226,101

 


 

226,101

 

Capitalized software, net

 

6,898,876

 


 

7,311,676

 

Intangible assets, net
17,640,833


21,609,794
Goodwill 
9,080,177


46,942,681
Other noncurrent assets
9,700


9,700
Total assets $ 43,169,057

$ 94,483,167








Liabilities and Equity

 

 

 


 

 

 

 

 

 

 


 

 

 

Current liabilities:

 

 

 


 

 

 

Accounts payable, accrued expenses and other accrued liabilities 

$

7,050,679

 


$

6,063,520

 

Contingent consideration payable
6,300,000


6,300,000

Current portion of deferred revenue 

 

2,403,512

 


 

3,543,819

 

Current portion of long-term debt
6,600,000


13,200,000
Derivative liability
11,282


63,178

Total current liabilities

 

22,365,473

 


 

29,170,517

 

 

 

 

 


 

 

 

Long-term portion of deferred revenue

602,086



582,676
Long-term debt, less current portion
6,788,000


4,105,000
    Deferred income tax liabilities
468,486


675,291
Total liabilities
30,224,045


34,533,484








Commitments and contingencies (Note 7)

 


 


 


 

 

 

 

 


 

 

Equity:

 

 

 


 

 

 

Preferred stock, par value $0.0001; 5,000,000 shares authorized, 1 share special voting preferred stock issued and outstanding at June 30, 2022 and December 31, 2021

 

 


 

 

Special voting preferred stock, par value $0.0001; 1 share authorized, issued and outstanding as of June 30, 2022 and December 31, 2021, with $1 preference in liquidation; exchangeable shares, no par value, 291,192 and 309,286 shares issued and outstanding as of June 30, 2022 and December 31, 2021 respectively
2,227,619


2,366,038

Common stock, par value $0.0001; 75,000,000 shares authorized, 36,826,733 and 31,001,884 issued and outstanding at June 30, 2022 and December 31, 2021, respectively

 

3,680

 


 

3,100

 

Additional paid-in capital

 

150,438,437

 


 

146,027,258

 

Accumulated other comprehensive income
302,352

61,523

Accumulated deficit

 

(140,027,076

)

 

(88,508,236

)

Total equity


12,945,012

 



59,949,683

 

Total liabilities and equity 

$

43,169,057

 


$

94,483,167

 

 The accompanying notes are an integral part of these condensed consolidated financial statements

1


AKERNA CORP.

 Condensed Consolidated Statements of Operations

(unaudited)

 

 


For the Three Months Ended

For the Six Months Ended

 

      


June 30,

June 30,

 

 


2022

2021


2022

 

 

2021

 

Revenue:








 

 

 

 

 

      Software

$ 5,920,929

$

4,456,728



$

12,429,442


 

$

8,251,881

 

      Consulting


115,300


410,884

 

542,309


 

 

583,631

 

      Other revenue


49,652


39,275

 

64,971


 

 

85,399

 

Total revenue


6,085,881


4,906,887

 

13,036,722


 

 

8,920,911

 

Cost of revenue


1,835,977


1,914,380

 

4,039,648


 

 

3,368,547

 

Gross profit


4,249,904


2,992,507

 

8,997,074

 

 

 

5,552,364

 

Operating expenses:









 

 

 

 

 

 

 

      Product development


1,761,428


1,527,258

 

3,866,789

 

 

 

2,951,358

 

      Sales and marketing
3,185,318


1,826,143


6,421,431


3,562,058

      General and administrative


2,419,109


4,375,981

 

4,989,541

 

 

 

6,228,943

 

      Depreciation and amortization
1,982,833


1,314,132


3,976,224


2,367,015
      Impairment of long-lived assets
24,122,066





39,600,587



Total operating expenses


33,470,754


9,043,514

 

58,854,572

 

 

 

15,109,374

 

Loss from operations


(29,220,850 )

(6,051,007 )

 

(49,857,498

)

 

 

(9,557,010

)

Other (expense) income:









 

 

 

 

 

 

 

      Interest (expense) income, net


(212,984 )

(163,125 )

 

(213,724

)

 

 

(937,505

)

      Change in fair value of convertible notes
(294,000 )

(16,405 )

(1,727,000 )

(2,007,677 )
      Change in fair value of derivative liability  
33,845


133,125


51,896

(42,871 )
Other expense (income), net



243





243

Total other (expense) income


(473,139 )

(46,162 )

 

(1,888,828

)

 

 

(2,987,810

)

















Net loss before income taxes and equity in losses of investee


(29,693,989 )

(6,097,169 )

(51,746,326 )

(12,544,820 )
         Income tax (expense) benefit
128,042


(4,300 )

227,486


(10,570 )
Equity in losses of investee



(3,782 )



(7,564 )
















Net loss

$ (29,565,947 )
$ (6,105,251 )

$

(51,518,840

)

 

$

(12,562,954

)

 









 

 

 

 

 

 

 

Basic and diluted weighted average common stock outstanding


35,477,788


24,530,169

 

33,694,681

 

 

 

23,375,981

 

Basic and diluted net loss per common share

$ (0.83 )
$ (0.25 )

$

(1.53

)

 

$

(0.54

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements


2


AKERNA CORP.
Condensed Consolidated Statements of Comprehensive Loss
(unaudited) 






Three Months Ended June 30, Six Months Ended June 30,

2022

2021


2022

2021
Net loss $ (29,565,947 ) $ (6,105,251 )
$ (51,518,840 )
$ (12,562,954 )
Other comprehensive (loss) income:













Foreign currency translation


10,629

2,183


(23,171 )

1,953
Unrealized (loss) gain on convertible notes
163,000

(3,000 )

264,000

(16,000 )
Comprehensive loss $ (29,392,318 ) $ (6,106,068 )
$ (51,278,011 )
$ (12,577,001 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

3


AKERNA CORP.

Condensed Consolidated Statements of Changes in Equity

For the Six Months Ended June 30, 2022

(unaudited)


    


Special Voting Preferred Stock

Common 

 


Additional
Paid-In



Accumulated Other Comprehensive

 


Accumulated

 


Total

 

 


Share

Amount

Shares

 


Amount

 


Capital



Income

 


Deficit

 


 Equity

 

 









 

 


 

 


 





 


 

 


 

 

Balance January 1, 2022
309,286

$ 2,366,038


31,001,884

$ 3,100

$ 146,027,258

$ 61,523
$ (88,508,236 )
$ 59,949,683
Conversion of Exchangeable Shares to common stock
(2,434 )

(18,620 )

2,434





18,620









Settlement of convertible debt






3,396,842


340


3,299,660








3,300,000
Shares withheld for withholding taxes






(4,421 )



(5,615 )







(5,615 )
Shares returned in connection with 365 Cannabis acquisition






(279,762 )

(28 )

(939,972 )







(940,000 )
Stock-based compensation












316,855








316,855
Restricted stock vesting






43,479


4


(4 )








Liabilities settled with shares






14,632


1


45,065








45,066
Foreign currency translation adjustments















(33,800 )




(33,800 )
Unrealized (loss) gain on convertible notes















101,000




101,000

Net loss








 


 

 


 




 


 

(21,952,893

)

 

(21,952,893

)

Balance – March 31, 2022


306,852

$ 2,347,418


34,175,088

 


$

3,417

 


$

148,761,867



$ 128,723

$

(110,461,129

)

$

40,780,296

Conversion of Exchangeable Shares to common stock
(15,660 )

(119,799 )

15,660


2


119,797









Settlement of convertible debt






751,686


75


625,425








625,500
Shares withheld for withholding taxes






(6,743 )




(7,552 )







(7,552 )
Shares issued in connection with the ATM program






1,816,184


182


760,996








761,178
Stock-based compensation












148,444








148,444
Restricted stock vesting






60,226


3


24,997








25,000
Liabilities settled with shares






14,632


1


4,463








4,464
Foreign currency translation adjustments















10,629





10,629
Unrealized (loss) gain on convertible notes















163,000





163,000
Net loss


















(29,565,947 )

(29,565,947 )
Balance – June 30, 2022
291,192

$ 2,227,619


36,826,733

$ 3,680

$ 150,438,437

$ 302,352

$ (140,027,076 )
$ 12,945,012

  

The accompanying notes are an integral part of these condensed consolidated financial statements


4



AKERNA CORP.

 Condensed Consolidated Statements of Changes in Equity

For the Six Months Ended June 30, 2021

(unaudited)


    


Special Voting Preferred Stock

Common 

 


Additional
Paid-In



Accumulated Other Comprehensive

 


Accumulated

 


Total

 

 


Share

Amount

Shares

 


Amount

 


Capital



Loss

 


Deficit

 


 Equity

 

 









 

 


 

 


 





 


 

 


 

 

Balance – January 1, 2021 
2,667,349

$ 20,405,219


19,901,248

$ 1,990

$ 94,086,433

$ (91,497 )
$ (57,179,525 )
$ 57,222,620
Conversion of Exchangeable Shares to common stock
(1,020,062 )

(7,803,475 )

1,020,062


102


7,803,373








Settlement of convertible debt






2,080,140


208


8,467,292








8,467,500
Shares withheld for withholding taxes






(48,948 )

(5 )

(333,842 )







(333,847 )
Stock-based compensation












503,379








503,379
Settlement of liabilities with shares






101,705


10


377,315








377,325
Restricted stock vesting






13,978


1


(1 )








Forfeitures of restricted shares






(668 )














Foreign currency translation adjustments















(230 )




(230 )
Unrealized (loss) gains on convertible notes















(13,000 )




(13,000 )

Net loss








 


 

 


 




 


 

(6,457,702

)

 

(6,457,702

)

Balance – March 31, 2021


1,647,287

$ 12,601,744


23,067,517

 


$

2,306

 


$

110,903,949



$ (104,727 )

$

(63,637,227

)

$

59,766,045

 

Conversion of Exchangeable Shares to common stock


(607,914 )

(4,650,541 )

607,914


62


4,650,479









Settlement of convertible debt






543,355



54



1,729,090









1,729,144
Shares withheld for withholding taxes






1,000,000


100


6,001,900








6,002,000
Stock-based compensation












571,242









571,242
Settlement of liabilities with shares
























Restricted stock vesting






114,321


11


(11 )










Forfeitures of restricted shares







(668 )















Foreign currency translation adjustments

















2,183






2,183
Unrealized (loss) gains on convertible notes

















(3,000 )




(3,000 )
Net loss




















(6,105,251 )

(6,105,251 )
Balance – June 30, 2021
1,039,373

$ 7,951,203


25,332,439


$
2,533

$ 123,856,649

$ (105,544 )
$ (69,742,478
)
$ 61,962,363

 

The accompanying notes are an integral part of these condensed consolidated financial statements


5


 AKERNA CORP.

Condensed Consolidated Statements of Cash Flows

(unaudited)

 

 

For the Six Months Ended

 

 

June 30,

 

 

2022

 


2021

 

Cash flows from operating activities:

 

 


 

 

Net loss $ (51,518,840 )
$ (12,562,954 )

Adjustment to reconcile net loss to net cash used in operating activities: 


 

 


 

 

 

Equity in losses of investment


 


 

7,564

 

Bad debt expense


112,475


 

150,294

 

Stock-based compensation expense, net


477,681

 


 

1,074,621

 

Loss on write off of fixed assets



1,045,180
Impairments of long-lived assets
39,600,587



Amortization of deferred contract cost
205,408


242,110
Non-cash interest expense
60,500


926,968
Depreciation and amortization
3,976,224


2,367,014
Foreign currency loss (gain)
14,689

(17,344 )
Change in fair value of convertible notes

1,727,000

2,007,677
Change in fair value of derivative liability
(51,896 )

42,871

Changes in operating assets and liabilities:



 


 



       Accounts receivable, net


(580,387

)

 

286,118

       Prepaid expenses and other current assets


23,530


 

(115,934

)
       Accounts payable, accrued expenses and other accrued liabilities
119,355

1,463,669
       Deferred income tax liabilities
(206,805 )


       Deferred revenue


(1,146,966

)

 

(633,052

)

Net cash used in operating activities


(7,187,445

)

 

(3,715,198

)

Cash flows from investing activities:


 

 


 

 

 

Developed software additions


(1,737,120

)

 

(2,004,609

)
Fixed asset additions

(27,383

)


Cash returned from business combination working capital settlement (Note 4)

400,000





Net cash used in investing activities


(1,364,503

)

 

(2,004,609

)

Cash flows from financing activities:


 

 


 

 

 

Value of shares withheld related to tax withholdings


(13,167 )

(333,847 )
Principal payments of convertible notes

(1,515,000 )


Proceeds received from stock offering, net
761,178



Net cash used in financing activities


(766,989

)

 

(333,847

)

Effect of exchange rate changes on cash and restricted cash


9,225


 

(124

)

Net change in cash and restricted cash


(9,309,712

)

 

(6,053,778

)

Cash and restricted cash - beginning of period


14,442,526

 


 

18,340,640

 

Cash and restricted cash - end of period

$

5,132,814

 


$

12,286,862

 

Cash paid for interest $ 151,500

$ 50,854
Cash paid for income taxes $ 19,466

$ 64,963
Supplemental disclosures of non-cash investing and financing activities: 






Settlement of convertible notes in common stock $ 3,925,500

$ 10,196,382
Conversion of exchangeable shares to common stock
138,419


12,453,853
Settlement of other liabilities in common stock
49,528


377,325
Stock-based compensation capitalized as software development
12,618



Vesting of restricted stock units
7



Capitalized software included in accrued expenses
1,045,299



Shares returned in connection with 365 Cannabis acquisition (Note 4)
940,000



365 Cannabis working capital reduction to accrued expenses (Note 4)
160,000



 

The accompanying notes are an integral part of these condensed consolidated financial statements

6


AKERNA CORP.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

Note 1 - Description of Business

 

Description of Business

 

Akerna Corp., herein referred to as we, us, our, the Company or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, the Company or Ample, solo sciences, inc., or Solo, Viridian Sciences Inc., or Viridian, and The NAV People, Inc. d.b.a. 365 Cannabis, or 365 Cannabis, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform®, Trellis®, Ample, Viridian and 365 Cannabis to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through Solo, we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG™. The integration of MJ Platform® and solo*CODE™ results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency.

 

Our Viridian and 365 Cannabis offerings are considered enterprise offerings while all other solutions are considered non-enterprise offerings that meet the needs of our small and medium-sized business, or SMB, customers.

 

We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations.

 

Going Concern and Management's Liquidity Plans

 

In accordance with the Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standard Update (ASU) No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (ASU 2014-15), we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash, cash equivalents and working capital on hand, including marketable equity securities, and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is defined to as the “look-forward period” in ASU 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to us, we will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions regarding implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable that such implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASU 2014-15.

 

The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception we have incurred recurring losses from operations, used cash from operating activities, and relied on capital raising transactions to continue ongoing operations. During the six months ended June 30, 2022 and June 30, 2021, we incurred losses from operations of $49.9 million and $9.6 million, respectively, and used cash in operating activities of $7.2 million and $3.7 million, respectively. As of June 30, 2022, we had a working capital deficit of $13.2 million with $5.1 million in cash available to fund future operations. Furthermore, on May 24, 2022, we received a notice (the “Notice”) from The Nasdaq Stock Market LLC indicating that the bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market (the “Nasdaq Market”). The Notice has no immediate effect on the continued listing status of our Common Stock on the Nasdaq Market, and, therefore, our listing remains fully effective. We are provided a compliance period of 180 calendar days from the date of the Notice, or until November 21, 2022, to regain compliance with the minimum closing bid requirement. These factors raise substantial doubt regarding the ability of  the Company to continue as a going concern.

 

 

7



 Management’s plan for the Company to continue as a going concern includes several initiatives and actions including those impacting our short and intermediate term financing, continuing costs, primarily labor and employee benefits, our working capital and the liquidity of our Common Stock. Certain of these initiatives and actions began during the quarter ended June 30, 2022 while others were initiated in July 2022.


The most significant components of our plan include the following: (i) realizing annualized cost savings associated with the corporate restructuring initiative (the “Restructuring”) that we announced in May 2022 which resulted in a reduction in workforce and related operating costs (see Note 4), (ii) entering into an amendment and waiver agreement to the securities purchase agreement associated with our 2021 Senior Convertible Notes (the “Senior Convertible Notes”) on June 30, 2022 (the “Convertible Notes Amendment”) which, among other factors, provides for a deferral of the required amortization payments due and payable from July 1, 2022 through January 1, 2023 (see Note 4), (iii) deploying for working capital needs of the net proceeds of approximately $2 million received from our offering of Common Stock and warrants (the “Unit Offering”) in a transaction that closed on July 5, 2022 (see Note 4), net of underwriting discounts and commissions and other offering expenses and after depositing $7 million of the proceeds into certain restricted cash accounts in accordance with the Convertible Notes Amendment, (iv) conservatively managing our working capital through disciplined cost-containment efforts and strategic management of our accounts receivable and accounts payable cycles (v) addressing the potential liquidity of our Common Stock in connection with the minimum listing requirements for the Nasdaq Market through a proposed 1-to-20 reverse stock split (the Reverse Stock Split”) and (vi) continuing to seek to grow our customer base and realize synergies as we continue to integrate our recent acquisitions.

We anticipate the initiatives and actions described above will provide us with sufficient liquidity in order to operate our business in the normal course for the second half of 2022  until such time that the an earn-out payment associated with a 2021 acquisition is due in December 2022 (see Note 4), in part, to the fact that the debt service obligations associated with the Senior Convertible Notes for the first half of 2023 have effectively been substantially pre-funded with the amounts deposited into restricted accounts as required by the Convertible Notes Amendment. In the second half of 2022, we plan to continue to rigorously explore potential financing alternatives and other strategic options in addition to enhancing the liquidity of our Common Stock. In addition to and to the extent practical in the future, based on market conditions, we will consider incremental offerings of Common Stock through our previously authorized ATM Program; however, we do not consider this a viable alternative unless and until we are able to successfully address the minimum listing requirements of the Nasdaq Market with the proposed Reverse Stock Split. Through July 31, 2022, we have utilized $2.7 million of the total $25 million authorized by the ATM Program.


If we are unable to secure other potential financing alternatives or fail to execute any other strategic options to raise sufficient additional funds through the first half of 2023, including through the ATM Program, we will have to develop and implement more aggressive plans to address our liquidity needs and our ability to satisfy the scheduled maturity of our obligations under the Senior Convertible Notes. Such plans could include extending payables, further reductions of expenditures (including the termination of additional employees) and reducing or eliminating investments in and the funding of certain of our business units and initiatives, or otherwise substantially scale back our business plan until sufficient additional capital is raised through other equity or debt offerings. Such offerings may include the issuance of shares of common stock, warrants to purchase common stock, preferred stock, convertible debt or other instruments that may dilute our current stockholders. Accordingly, we may be subject to additional risks, including retention of key employees and limitations on the extension of credit by our vendors and other service providers. If we are required to raise additional capital as discussed above and if we cannot timely raise additional funds, we may be unable to meet the financial covenants of the Senior Convertible Notes, which could result in an event of default under those instruments which could adversely impact the Company. See the risks detailed in our Form 10-K under “Item 1A. Risk Factors – Risks Relating to our Convertible Debt”.

 

Our ability to continue as a going concern is dependent upon our ability to successfully execute the plans described above and attain profitable operations. Despite the comprehensive scope of our plans, the inherent risks associated with their successful execution are not sufficient to fully overcome substantial doubt about our ability to continue as a going concern for one year from the date of issuance of the consolidated financial statements. Accordingly, if we are unable to raise sufficient capital we may have to reduce operations which could significantly and adversely affect our results of operations. If we fail to meet the financial covenants of the Senior Convertible Notes and cannot obtain a waiver from such provisions or otherwise come to an agreement with the holders of our debt, such holders may declare a default on the debt which could subject our assets to seizure and sale, negatively impacting our business.


The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary if the Company is unable to continue as a going concern.

 

8



Note 2 - Summary of Significant Accounting Policies

 

Basis of Presentation


The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to the Quarterly Report on Form 10-Q and Article 8 of Regulation S-X for interim financial information. Accordingly, these financial statements do not include all of the information normally required by GAAP or Securities and Exchange Commission rules and regulations for complete financial statements. In management’s opinion, these condensed consolidated financial statements include all adjustments, consisting of normal recurring items, considered necessary for the fair presentation of the results of operations for the interim periods presented. The operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. 


The condensed consolidated balance sheet as of and for the period ended December 31, 2021, has been derived from our audited financial statements at that date but does not include all disclosures and financial information required by GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and notes thereto for the period ended December 31, 2021, which were included in our report on Form 10-K filed on June 30, 2022. 

 

Principles of Consolidation

 

Our accompanying consolidated financial statements include the accounts of Akerna and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.


Use of Estimates


The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expenses, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. 


Subsequent Events


Management has evaluated all of our activities through the issuance date of our condensed consolidated financial statements and has concluded that, with the exception of the issuance of common stock and warrants in an offering that closed on July 5, 2022, as disclosed in Note 4, no subsequent events have occurred that would require recognition in our condensed consolidated financial statements or disclosure in the notes thereto.


Accounts Receivable, Net

 

We maintain an allowance for doubtful accounts equal to the estimated uncollectible amounts based on our historical collection experience and review of the current status of trade accounts receivable. Receivables are written-off and charged against the recorded allowance when we have exhausted collection efforts without success. The allowance for doubtful accounts was $0.7 million and $0.3 million as of June 30, 2022 and December 31, 2021, respectively.


Concentrations of Credit Risk


We grant credit in the normal course of business to customers in the United States and Canada. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. 


During the six months ended June 30, 2022 and 2021, one government client accounted for 11% and 11% of total revenues, respectively.  As of June 30, 2022, one government client accounted for 30% of net accounts receivable and as of December 31, 2021 two government clients accounted for 37% of net accounts receivable. 

 

9


 

Segment Reporting

 

We operate our business as one operating segment. Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker (CODM), our Chief Executive Officer, in deciding how to allocate resources and assess performance. Our CODM allocates resources and assesses performance based upon discrete financial information at the consolidated level. 

 

In the following table, we disclose the combined gross balance of our fixed assets, capitalized software, and intangible assets by geographical location (in thousands):

 


As of June 30, 2022


As of December 31, 2021

Long-lived assets:






United States $ 28,231

$ 32,356
Canada 
5,932


5,229
Total $ 34,163

$ 37,585

 


Adoption of Recent Accounting Pronouncements

 

The FASB issued ASU No. 2016-02, Leases (ASU 2016-02) which, together with related amendments to GAAP, represents ASC Topic 842, Leases (ASC 842). ASC 842 superseded all prior GAAP with respect to leases. ASC 842 established a right-of-use model which requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases are to be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. We adopted ASC 842 effective January 1, 2022 and due to the immaterial impact of applying this standard to our limited assets subject to operating leases, there was no material impact to our balance sheets and statements of operations.


The FASB issued ASU No. 2020-01, Clarifying the Interaction between Topic 321, Topic 323, and Topic 815 (ASU 2020-01) which provides guidance clarifying interactions between various standards governing investments in equity securities. The guidance addresses accounting for the transition into and out of the equity method and measurement of certain purchased options and forward contracts to acquire investments. We adopted ASU 2020-01 effective January 1, 2022 and there was no material impact to our balance sheets and statements of operations.


10


 

The FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options, (ASU 2021-04) which provides clarification and reduces diversity in practice with respect to an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. We adopted ASU 2021-04 effective January 1, 2022 and there was no material impact to our balance sheets and statements of operations.


Recent Accounting Pronouncements Pending Adoption


The FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (ASU 2016-13) which introduced a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. ASU 2016-13 requires and entity to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. ASU 2016-13, and subsequent amendments, is effective for us beginning on January 1, 2023. We are currently evaluating the impact of the adoption of ASU 2016-13 on our consolidated financial statements.


The FABS issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (ASU 2020-06), which simplified the accounting for convertible instruments. ASU 2020-06 eliminated certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, ASU 2020-06 eliminates certain of the conditions for equity classification for contracts in an entity's own equity. ASU 2020-06 also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effects of shares settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. ASU 2020-06 is required to be adopted by us beginning on January 1, 2023 and must be applied using either a modified or full retrospective approach. We are currently evaluating the impact ASU 2020-06 will have on our consolidated financial statements.


The FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08), which amends the accounting related to contract assets and liabilities acquired in business combinations. Under current GAAP, an entity generally recognizes assets and liabilities acquired in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU 2021-08 requires that entities recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to businesses combinations occurring on or after the effective date of the amendment. We are currently evaluating the impact this guidance will have on our consolidated financial statements.


Note 3 – Revenue

  

We recognize revenue when a customer obtains the benefit of promised services, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. In determining the amount of revenue to be recognized, we perform the following steps: (i) identification of the contract with a customer; (ii) identification of the promised services in the contract and determination of whether the promised services are performance obligations, including whether they are distinct in the context of the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. 


Software Revenue. Our software revenue is generated from subscriptions and services related to the use of our commercial software platforms, MJ Platform®, Ample, Trellis, Viridian, 365 Cannabis, and our government regulatory platform, Leaf Data Systems, and the sale of business intelligence, data analytics and other software related services. For our SMB customers, software contracts are generally annual contracts paid monthly in advance of service and typically cancellable upon 30 days’ notice after the end of the contract period. Leaf Data Systems contracts are generally multi-year contracts payable annually or quarterly in advance of service. Commercial software and Leaf Data Systems contracts generally may only be terminated early for breach of contract as defined in the respective agreements. Our enterprise contracts are typically multi-year contracts paid monthly in advance of services and are generally cancellable with at least one month's notice before the end of the contract period. Amounts that have been invoiced are initially recorded as deferred revenue or contract liabilities. Subscription revenue is recognized on a straight-line basis over the service term of the arrangement beginning on the date that our solution is made available to the customer and ending at the expiration of the subscription term. We typically invoice customers at the beginning of the term, in multi-year, annual, quarterly, or monthly installments. When a collection of fees occurs in advance of service delivery, revenue recognition is deferred until such services commence. Revenue for implementation fees is recognized ratably over the expected term of the contract, including expected renewals.

 

11


 

We include service level commitments to customers warranting certain levels of uptime reliability and performance and permitting those customers to receive credits if those levels are not met. In addition, customer contracts often include: specific obligations that require us to maintain the availability of the customer’s data through the service and that customer content is secured against unauthorized access or loss, and indemnity provisions whereby we indemnify customers from third-party claims asserted against them that result from our failure to maintain the availability of their content or securing the same from unauthorized access or loss. To date, we have not incurred any material costs as a result of such commitments. Any such credits or payments made to customers under these arrangements are recorded as a reduction of revenue.


Consulting Revenue. Consulting services revenue is generated by providing solutions for operators in the pre-application of licensures and pre-operational phases of development and consists of contracts with fixed terms and fee structures based upon the volume and activity or fixed-price contracts for consulting and strategic services. These services include application and business plan preparation as they seek licenses to be granted. Consulting projects completed during the pre-application phase generally solidify us as the software vendor of choice for subsequent operational phases once the operator is granted the license. As a result, our consulting revenue is driven as new emerging states pass legislation, and as our client-operators gain licenses. When these services are not combined with subscription revenues as a single unit of account, these revenues are recognized as services are rendered and accepted by the customer. 

 

Other Revenue. Our other revenue is derived primarily from point-of-sale hardware and other non-recurring revenue. We recognize revenue as these products are delivered and title has transferred.

 

Cost of Revenue. Cost of revenue consists primarily of costs related to providing subscription and other services to our customers, including employee compensation and related expenses for data center operations, customer support and professional services personnel, payments to outside technology service providers, security services, and other tools.

 

Deferred Revenue. Deferred revenue consists of payments received in advance of revenue recognition from subscription, implementation and consulting services. The deferred revenue balance is influenced by several factors, including seasonality, the compounding effects of renewals, contract duration, and invoice frequency. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as deferred revenue, which is presented as a current liability while amounts that will be recognized in periods greater than twelve months in the future are recognized as a noncurrent liability on the accompanying consolidated balance sheets. 


Disaggregation of Revenue

We derive the majority of our revenue from subscription fees paid for access to and usage of our software as a service, or SaaS, solutions for a specified period of time, typically one to three years. In addition to subscription fees, contracts with customers may include implementation fees for launch assistance and training. Fixed subscription and implementation fees are billed in advance of the subscription term and are due in accordance with contract terms, which generally provide for payment within 30 days. Our contractual arrangements include performance, termination and cancellation provisions, but do not provide for refunds. Customers do not have the contractual right to take possession of tour software at any time.


Sales taxes collected from customers and remitted to government authorities are excluded from revenue.

12



The following tables summarizes our revenue disaggregation of enterprise offerings and non-enterprise offerings for the following periods (in thousands):


Six Months Ended June 30,



2022


2021

Enterprise

$

5,898

 


$

1,638


Non-enterprise

7,139

 


7,283


 

$

13,037

 


$

8,921




Six Months Ended June 30,



2022


2021

United States

$

9,243

 


$

6,267


Canada

3,794

 


2,654


 

$

13,037

 


$

8,921


 

Contracts with Multiple Performance Obligations


Customers may elect to purchase a subscription to multiple modules, multiple modules with multiple service levels, or, for certain of the Company's solutions. We evaluate such contracts to determine whether the services to be provided are distinct and accordingly should be accounted for as separate performance obligations. If we determine that a contract has multiple performance obligations, the transaction price, which is the total price of the contract, is allocated to each performance obligation based on a relative standalone selling price method. We estimate standalone selling price based on observable prices in past transactions for which the product offering subject to the performance obligation has been sold separately. As the performance obligations are satisfied, revenue is recognized as discussed above in the product descriptions.


13


 

Transaction Price Allocated to Future Performance Obligation


GAAP provides certain practical expedients that limit the required disclosure of the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied. As many of the contracts the Company has entered into with customers are for a twelve-month subscription term, a significant portion of performance obligations that have not yet been satisfied as of June 30, 2022 are part of a contract that has an original expected duration of one year or less. For contracts with an original expected duration of greater than one year, for which the practical expedient does not apply, the aggregate transaction price allocated to the unsatisfied performance obligations was $22.3 million as of June 30, 2022, of which $11.9 million is expected to be recognized as revenue over the next twelve months.   


Deferred Revenue

 

Deferred revenue represents the unearned portion of subscription and implementation fees. Deferred revenue is recorded when cash payments are received in advance of performance. Deferred amounts are generally recognized within one to three years. Deferred revenue is included in the accompanying consolidated balance sheets under current liabilities, net of any long-term portion that is included in noncurrent liabilities.

 

The following table summarizes deferred revenue activity for the six months ended June 30, 2022 (in thousands):

 

 

As of
December 31, 2021

 


Net additions

 


Revenue recognized

 


As of
June 30, 2022

Deferred revenue

$

4,126

 


8,881

 


(10,002

)

$

3,005

 

Of the $13.0 million of revenue recognized in the six months ended June 30, 2022, $3.1 million was included in deferred revenue at December 31, 2021.

 

Costs to Obtain Contracts


We capitalize sales commissions that are directly related to obtaining customer contracts and that would not have been incurred if the contract had not been obtained. These costs are included in the accompanying consolidated balance sheets and are classified as a component of Prepaid expenses and other current assets. Deferred contract costs are amortized to sales and marketing expense over the expected period of benefit, which we have determined to be one to three years based on the estimated customer relationship period.    


The following table summarizes deferred contract cost activity for the six months ended June 30, 2022 (in thousands):

 

 

As of
December 31, 2021

 


Additions

 


Amortized costs 

 


As of
June 30, 2022

Deferred contract costs

$

261

 


279

 


(246 )

$

294

 

14


Note 4 – Significant Transactions

 

Convertible Notes Amendment

On June 30, 2022, we and the holders Senior Convertible Notes entered into the Convertible Notes Amendment to add covenants such that (a) we will be subject to a daily cash test beginning on July 1, 2022 of having an available cash balance of at least $7 million, which amount shall be reduced by $1 million on each of the dates at which the aggregate principal due upon the Senior Convertible Notes is equal to or less than $14 million and $11 million, subject in all cases to a minimum of $5 million, and (b) we will establish and maintain bank accounts for each holder and deposit in such accounts an aggregate amount of $7 million with such amount to be released from the accounts only upon the written consent of such holder, provided that $1 million will automatically release from the accounts upon the occurrence of each of the dates at which the aggregate principal due upon the Senior Convertible Notes is equal to or less than $14 million and $11 million, subject to certain conditions. Further the holders of the Senior Convertible Notes waived provisions such that (i) no amortization payments are due and payable for any payments previously required to be made from July 1, 2022 through January 1, 2023, (ii) the holders of the Senior Convertible Notes will not accelerate any previously deferred installment amounts until January 1, 2023 and (iii) the terms of the Senior Convertible Notes which would provide for reset of the conversion price of the Senior Convertible Notes as a result of the issuance of securities under the Unit Offering and instead agree to a reset of the conversion price equal to a per share price of 135% of the Unit Offering price, or $0.3105 per unit.

Unit Offering

On June 30, 2022, we entered into an underwriting agreement (the “Underwriting Agreement”) with A.G.P./Alliance Global Partners (the “Underwriter”), in connection with the Unit Offering which is comprised of an aggregate of (i) 29,382,861 units of the Company consisting of 29,382,861 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 29,382,861 shares of Common Stock and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-Funded Warrants”), with each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Warrants to purchase up to 14,095,400 shares of Common Stock. The units were sold at a public offering price of $0.23 per unit and the pre-funded units were sold at a public offering price of $0.2299 per pre-funded unit. Each Share and each Pre-Funded Warrant was sold with an accompanying Common Warrant but were issued separately and are immediately tradeable separately upon issuance.

The Pre-Funded Warrants are immediately exercisable at a nominal exercise price of $0.0001 or on a cashless basis and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. The Common Warrants have an exercise price of $0.23 per share subject to certain adjustments, are immediately exercisable and will expire five years from the date of issuance.

The Pre-Funded Warrants were sold to purchasers whose purchase of shares of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or at the election of the purchaser, 9.99%) of our outstanding Common Stock immediately following the consummation of the Unit Offering, in lieu of shares of Common Stock. Each Pre-Funded Warrant represents the right to purchase one share of Common Stock at an exercise price of $0.0001 per share.

Pursuant to the Underwriting Agreement, we granted the Underwriter a 45-day option from June 30, 2022 to purchase from the Company (i) additional shares of Common Stock and/or (ii) Common Warrants and/or (iii) Pre-Funded Warrants, in any combination thereof, up to, and not to exceed, 13,043,478 shares of Common Stock or shares of Common Stock underlying Pre-Funded Warrants or Common Warrants, in the aggregate, solely to cover over-allotments, if any.

Pursuant to the  Underwriting Agreement and upon closing of the Unit Offering, we issued to the Underwriter warrants to purchase up to 2,173,913 shares of Common Stock (the “Underwriter Warrants” and, together with the Common Warrants and the Pre-Funded Warrants, the “Warrants”), which is 5.0% of the aggregate number of Shares and Shares issuable upon exercise of the Pre-Funded Warrants sold in the Unit Offering. The Underwriter Warrants are exercisable at any time and from time to time, in whole or in part, commencing from six months after June 29, 2022 (the "Effective Date") and ending five years from the Effective Date, at a price per share equal to $0.23, which is the public offering price per unit.

The Unit Offering closed on July 5, 2022 and we received net proceeds of approximately $9.3 million after deducting underwriting discounts and commissions and related expenses. In connection with the Convertible Notes Amendment, a total of $7 million of the proceeds were deposited into certain restricted cash accounts. We intend to use the remaining net proceeds from the Unit Offering for general corporate purposes, including working capital, marketing, product development and capital expenditures.

Restructuring

In May 2022, we implemented the Restructuring as approved by our board of directors. The Restructuring resulted in a reduction of the Company's workforce by 59 employees, or approximately 33 percent of the Company. We incurred costs of approximately $0.5 million in severance benefits, including employee insurance, associated payroll taxes and legal costs in connection with the Restructuring. Of the total amount incurred, $0.3 million was included in Sales and marketing costs, $0.2 million was recorded in Product development and less than $0.1 million was included in Cost of revenue and General and administrative expenses, respectively. All amounts directly attributable to the severed employees were settled in cash during the quarter ended June 30, 2022. Accordingly, we have no material obligations remaining associated with the Restructuring. In addition to the reduction in force, the Company's executive leadership team agreed to a temporary 25 percent reduction in salary, subject to certain conditions.


15



2021 Transactions


Viridian Sciences

 

On April 1, 2021, we completed the acquisition of Viridian Sciences Inc. (“Viridian”), a cannabis business management software provider that is built on SAP Business One. We acquired Viridian in exchange for 1.0 million shares of our common stock valued at $6.0 million. In addition to the stock consideration, the agreement provides for contingent consideration of up to $1.0 million, payable in additional common stock, if Viridian meets certain revenue criteria. We finalized our purchase price accounting during the three months ended March 31, 2022 and there were no changes to the previously disclosed purchase price accounting. 


365 Cannabis

 

On October 1, 2021, we acquired all the issued and outstanding shares of 365 Cannabis. Under the terms of the stock purchase agreement (the Stock Purchase Agreement), the aggregate consideration for the 365 Cannabis shares consisted of an initial purchase price of (1) $5,000,000 in cash, (2) $12,000,000 in stock, which was to be settled by issuing 3.6 million shares of our common stock, and (3) contingent value rights to be issued pursuant to a rights indenture entitling the holders thereof to receive, subject to certain adjustments as set forth in the Agreement, an aggregate of up to $8,000,000 in stock, in the event that 365 Cannabis achieves certain revenue targets as specified in the Agreement. These rights are accounted for as contingent consideration and are currently recorded at preliminary fair value which will be updated upon finalization of purchase accounting.


We reached a working capital settlement agreement during the first quarter of 2022 in the amount of $1.5 million. As a result of this post-close adjustment, the 365 Cannabis purchase price was reduced by $1.5 million. This was recorded as follows: 1) a receivable of $400,000 was booked in other current assets in our condensed consolidated balance sheet as of March 31, 2022 and was received in the second quarter of 2022, 2) a reduction of $160,000 was made to the working capital accrual that was booked as of December 31, 2021, and 3) 279,762 shares worth $940,000 that were held in escrow were released back to Akerna to cover the remainder of the working capital adjustment.


On May 23, 2022, we and the sellers of 365 Cannabis entered into an amendment (the "Amendment") to the Stock Purchase Agreement in order to provide the Sellers an election to have the potential earn-out payment, recognized as contingent consideration in the table below, paid in cash or Common Stock or in any combination thereof. Under the Amendment, if a seller elects to have any portion of the earn-out payment paid in cash such amount payable will be reduced by 25%.


The updated consideration transferred is reflected in the table below (in thousands): 

 

 

 

Preliminary
Fair Value

 

Shares issued

 

$

11,060

 

Cash

4,982
Contingent consideration

6,300
Total preliminary fair value of consideration transferred
$ 22,342

 

The opening balance sheet presented below reflects our updated purchase price allocation, summarizing the preliminary fair values of assets acquired and liabilities assumed as of the date of acquisition (in thousands): 

 

 

 

Preliminary
Fair Value

 

Cash
$ 527
Accounts receivable

 

 

486

 

Prepaid expenses and other current asset

261
Fixed assets

93
Non-compete agreement

80